Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology - PubMed (original) (raw)
Review
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al. Physiol Rev. 2008 Jul.
Free article
Abstract
The membrane proteins CD38 and CD157 belong to an evolutionarily conserved family of enzymes that play crucial roles in human physiology. Expressed in distinct patterns in most tissues, CD38 (and CD157) cleaves NAD(+) and NADP(+), generating cyclic ADP ribose (cADPR), NAADP, and ADPR. These reaction products are essential for the regulation of intracellular Ca(2+), the most ancient and universal cell signaling system. The entire family of enzymes controls complex processes, including egg fertilization, cell activation and proliferation, muscle contraction, hormone secretion, and immune responses. Over the course of evolution, the molecules have developed the ability to interact laterally and frontally with other surface proteins and have acquired receptor-like features. As detailed in this review, the loss of CD38 function is associated with impaired immune responses, metabolic disturbances, and behavioral modifications in mice. CD38 is a powerful disease marker for human leukemias and myelomas, is directly involved in the pathogenesis and outcome of human immunodeficiency virus infection and chronic lymphocytic leukemia, and controls insulin release and the development of diabetes. Here, the data concerning diseases are examined in view of potential clinical applications in diagnosis, prognosis, and therapy. The concluding remarks try to frame all of the currently available information within a unified working model that takes into account both the enzymatic and receptorial functions of the molecules.
Similar articles
- Identification of a major enzyme for the synthesis and hydrolysis of cyclic ADP-ribose in amphibian cells and evolutional conservation of the enzyme from human to invertebrate.
Ikeda T, Takasawa S, Noguchi N, Nata K, Yamauchi A, Takahashi I, Yoshikawa T, Sugawara A, Yonekura H, Okamoto H. Ikeda T, et al. Mol Cell Biochem. 2012 Jul;366(1-2):69-80. doi: 10.1007/s11010-012-1284-0. Epub 2012 Mar 16. Mol Cell Biochem. 2012. PMID: 22422046 - The ADP-ribosyl cyclases--the current evolutionary state of the ARCs.
Ferrero E, Lo Buono N, Horenstein AL, Funaro A, Malavasi F. Ferrero E, et al. Front Biosci (Landmark Ed). 2014 Jun 1;19(6):986-1002. doi: 10.2741/4262. Front Biosci (Landmark Ed). 2014. PMID: 24896331 Review. - Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase.
Liu Q, Graeff R, Kriksunov IA, Jiang H, Zhang B, Oppenheimer N, Lin H, Potter BV, Lee HC, Hao Q. Liu Q, et al. J Biol Chem. 2009 Oct 2;284(40):27637-45. doi: 10.1074/jbc.M109.031005. Epub 2009 Jul 28. J Biol Chem. 2009. PMID: 19640846 Free PMC article. - CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.
Malavasi F, Deaglio S, Ferrero E, Funaro A, Sancho J, Ausiello CM, Ortolan E, Vaisitti T, Zubiaur M, Fedele G, Aydin S, Tibaldi EV, Durelli I, Lusso R, Cozno F, Horenstein AL. Malavasi F, et al. Mol Med. 2006 Nov-Dec;12(11-12):334-41. doi: 10.2119/2006–00094.Malavasi. Mol Med. 2006. PMID: 17380201 Free PMC article. Review. - Evidence for an intracellular ADP-ribosyl cyclase/NAD+-glycohydrolase in brain from CD38-deficient mice.
Ceni C, Muller-Steffner H, Lund F, Pochon N, Schweitzer A, De Waard M, Schuber F, Villaz M, Moutin MJ. Ceni C, et al. J Biol Chem. 2003 Oct 17;278(42):40670-8. doi: 10.1074/jbc.M301196200. Epub 2003 Aug 8. J Biol Chem. 2003. PMID: 12909645
Cited by
- Dual roles of extracellular vesicles in acute lymphoblastic leukemia: implications for disease progression and theranostic strategies.
Lajevardi MS, Ashrafpour M, Mubarak SMH, Rafieyan B, Kiani A, Noori E, Roayaei Ardakani M, Montazeri M, Kouhi Esfahani N, Asadimanesh N, Khalili S, Payandeh Z. Lajevardi MS, et al. Med Oncol. 2024 Nov 22;42(1):11. doi: 10.1007/s12032-024-02547-7. Med Oncol. 2024. PMID: 39572459 Free PMC article. Review. - CD56briCD38+ as a novel neutrophil-specific marker in chronic myeloid leukemia.
Huang P, Zhang C, Zhang A, Mao J, Liu G, Hu C, Zhu H. Huang P, et al. Heliyon. 2024 Oct 24;10(21):e39465. doi: 10.1016/j.heliyon.2024.e39465. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39559206 Free PMC article. - NAD+ enhancers as therapeutic agents in the cardiorenal axis.
Marín-Blázquez M, Rovira J, Ramírez-Bajo MJ, Zapata-Pérez R, Rabadán-Ros R. Marín-Blázquez M, et al. Cell Commun Signal. 2024 Nov 8;22(1):537. doi: 10.1186/s12964-024-01903-4. Cell Commun Signal. 2024. PMID: 39516787 Free PMC article. Review. - Immunometabolism: signaling pathways, homeostasis, and therapeutic targets.
Xu R, He X, Xu J, Yu G, Wu Y. Xu R, et al. MedComm (2020). 2024 Nov 3;5(11):e789. doi: 10.1002/mco2.789. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39492834 Free PMC article. Review. - CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 axis.
Liang L, Yue C, Li W, Tang J, He Q, Zeng F, Cao J, Liu S, Chen Y, Li X, Zhou Y. Liang L, et al. Heliyon. 2024 Sep 19;10(19):e37958. doi: 10.1016/j.heliyon.2024.e37958. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous